These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9508409)

  • 21. Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia.
    Ding K; Shibui A; Wang Y; Takamoto M; Matsuguchi T; Sugane K
    Microbes Infect; 2005 Feb; 7(2):195-203. PubMed ID: 15725383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection.
    Iriart X; Witkowski B; Courtais C; Abbes S; Tkaczuk J; Courtade M; Cassaing S; Fillaux J; Blancher A; Magnaval JF; Pipy B; Berry A
    Med Mycol; 2010 Dec; 48(8):1075-87. PubMed ID: 20470237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii.
    Ishimine T; Kawakami K; Nakamoto A; Saito A
    Microbiol Immunol; 1995; 39(1):49-58. PubMed ID: 7783677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumonia.
    Liao CP; Lasbury ME; Wang SH; Zhang C; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S134-5. PubMed ID: 17169031
    [No Abstract]   [Full Text] [Related]  

  • 25. Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradation of Pneumocystis carinii in rat alveolar macrophages.
    Hoyte JS; Standing JE; Limper AH
    Inflammation; 1997 Jun; 21(3):335-45. PubMed ID: 9246575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
    Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
    J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of alveolar macrophages in host defense against Pneumocystis carinii.
    Martin WJ; Pasula R
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):434-5. PubMed ID: 11017906
    [No Abstract]   [Full Text] [Related]  

  • 28. GM-CSF expression in the lung during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S124-6. PubMed ID: 17169027
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms of defence in the lung: lessons from Pneumocystis carinii pneumonia.
    Vassallo R; Thomas CF; Vuk-Pavlovic Z; Limper AH
    Sarcoidosis Vasc Diffuse Lung Dis; 2000 Jun; 17(2):130-9. PubMed ID: 10957761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia.
    Krishnan VL; Meager A; Mitchell DM; Pinching AJ
    Clin Exp Immunol; 1990 May; 80(2):156-60. PubMed ID: 2357841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta activation and signaling in the alveolar environment during Pneumocystis pneumonia.
    Ray CA; Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S127-9. PubMed ID: 17169028
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis and host response in Pneumocystis carinii pneumonia.
    Su TH; Martin WJ
    Annu Rev Med; 1994; 45():261-72. PubMed ID: 8198382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.
    Wang J; Gigliotti F; Bhagwat SP; George TC; Wright TW
    PLoS Pathog; 2010 Aug; 6(8):e1001058. PubMed ID: 20808846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.
    Zhang ZQ; Wang J; Hoy Z; Keegan A; Bhagwat S; Gigliotti F; Wright TW
    Infect Immun; 2015 Dec; 83(12):4594-603. PubMed ID: 26371121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in alveolar macrophage number during Pneumocystis carinii infection.
    Lasbury ME; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2003; 50 Suppl():630-1. PubMed ID: 14736191
    [No Abstract]   [Full Text] [Related]  

  • 36. Toll-like receptor 2 knockout reduces lung inflammation during Pneumocystis pneumonia but has no effect on phagocytosis of Pneumocystis organisms by alveolar macrophages.
    Zhang C; Wang SH; Liao CP; Lasbury ME; Durant PJ; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S132-3. PubMed ID: 17169030
    [No Abstract]   [Full Text] [Related]  

  • 37. Pneumocystis carinii induction of tumor necrosis factor-alpha by alveolar macrophages: modulation by pentamidine isethionate.
    Corsini E; Dykstra C; Craig WA; Tidwell RR; Rosenthal GJ
    Immunol Lett; 1992 Dec; 34(3):303-8. PubMed ID: 1487315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural observation of Pneumocystis carinii in bronchoalveolar lavage fluid from non-AIDS patients with P carinii pneumonia.
    Ishida T; Matsui Y; Matsumura Y; Furutani M
    Chest; 1994 May; 105(5):1342-6. PubMed ID: 8181316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of immunoblotting to detect soluble Pneumocystis carinii antigen(s) in bronchoalveolar lavage of patients with Pneumocystis pneumonia and AIDS.
    Sethi KK
    J Clin Pathol; 1990 Jul; 43(7):584-6. PubMed ID: 2380406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.
    Atochina EN; Gow AJ; Beck JM; Haczku A; Inch A; Kadire H; Tomer Y; Davis C; Preston AM; Poulain F; Hawgood S; Beers MF
    J Infect Dis; 2004 Apr; 189(8):1528-39. PubMed ID: 15073692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.